Scully M, Cataland SR, Peyvandi F, et al. Results of the Randomized, Double-Blind, Placebo-Controlled, Phase 3 Hercules Study of Caplacizumab in Patients with Acquired Thrombotic Thrombocytopenic Purpura. ASH 59th Annual Meeting & Exhibition, abstract LBA-1.
Ibrutinib-venetoclax bij CLL leidt vaker tot niet-detecteerbare MRD
sep 2025 | Leukemie